Iron reduction response and demographic differences between diabetics and non-diabetics with cardiovascular disease entered into a controlled clinical trial-Reference-Cited by-同舟云学术

Iron reduction response and demographic differences between diabetics and non-diabetics with cardiovascular disease entered into a controlled clinical trial

Published:2018 Issue:2 Volume:10 Page:264-277
ISSN:1756-5901
Container-title:Metallomics
language:en
Short-container-title:Metallomics

Author:

Zacharski Leo R.¹²³⁴⁵^ORCID,Shamayeva Galina⁶⁷⁸⁵^ORCID,Chow Bruce K.⁶⁷⁸⁵^ORCID

Affiliation:

1. Veterans Affairs New England Health Care System

2. Research Service (151)

3. VA Medical Center

4. White River Jct.

5. USA

6. Veterans Affairs Cooperative Studies Program Coordinating Center

7. Veterans Affairs Palo Alto Health Care System

8. Palo Alto

Abstract

Filings of elemental iron separated magnetically from a homogenate of breakfast cereal implicated in the risk of cardiovascular disease and diabetes.

Funder

U.S. Department of Veterans Affairs

Publisher

Oxford University Press (OUP)

Subject

Metals and Alloys,Biochemistry,Biomaterials,Biophysics,Chemistry (miscellaneous)

Link

http://pubs.rsc.org/en/content/articlepdf/2018/MT/C7MT00282C

Reference169 articles.

1. Atherogenesis and iron: from epidemiology to cellular level

2. The Role of Iron in the Pathogenesis of Atherosclerosis

3. Fe(III) distribution varies substantially within and between atherosclerotic plaques

4. Iron status and its association with coronary heart disease: Systematic review and meta-analysis of prospective studies

5. Epidemiological associations between iron and cardiovascular disease and diabetes

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural characterization and anti-oxidation activity evaluation of pectin from Lonicera japonica Thunb.;Frontiers in Nutrition;2022-09-20

2. Optimal serum ferritin level range: iron status measure and inflammatory biomarker;Metallomics;2021-05-28

3. Antioxidant activities and mechanisms of polysaccharides;Chemical Biology & Drug Design;2020-10-08

4. FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson’s Disease;Neurotherapeutics;2020-09-21

5. A fully human anti-BMP6 antibody reduces the need for erythropoietin in rodent models of the anemia of chronic disease;Blood;2020-08-27